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SYNOPSIS (100 words) 15 
Pharmacological management of exercise induced bronchoconstriction (EIB) is the mainstay 16 
of preventative therapy. However, there are some non-pharmacological interventions that may 17 
assist the management of EIB. In this review we will discuss these non-pharmacological 18 
interventions and how they may be applied to patients and athletes with EIB. 19 
 20 
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KEY POINTS: 26 
x There is emerging evidence that non-pharmacological strategies can be used to 27 
supplement traditional therapy to reduce exercise-induced bronchoconstriction (EIB) 28 
severity and lessen respiratory symptoms associated with exercise 29 
x Most investigations into non-pharmacological have included non-athletes, 30 
extrapolating towards athletes should be done with caution and studies in athletes with 31 
EIB are encouraged.  32 
x There is currently insufficient evidence to support the use of any non-pharmacological 33 
EIB treatment strategy in the absence of regular pharmaceutical therapy for EIB.  34 
 35 
INTRODUCTION 36 
Exercise-induced bronchoconstriction (EIB) is an asthma-related condition, which occurs 37 
during or following exercise DVDUHVXOWRIODUJHYROXPHVRIµXQFRQGLWLRQHGDLU¶HQWHULQJWKH38 
lower airways to meet the increased ventilatory demands of exercise1,2. In susceptible 39 
individuals, EIB arises via multiple mechanisms that may involve dehydration of airway 40 
surface liquid, mucosal cooling and epithelial damage (ref to pathophysiology paper in series), 41 
which induces an airway inflammatory response (involving histamine, neuropeptides, 42 
leukotrienes and prostaglandins) with resultant airway smooth muscle constriction3. 43 
Management of EIB in athletes is almost exclusively based around pharmacological therapies 44 
(ref to pharmacological paper in series)VXFKDVJOXFRFRUWLFRLGVDQGȕ2-Agonists1,2. Although 45 
clinical data on non-pharmacological therapies has been equivocal, there is emerging evidence 46 
that non-pharmacological strategies could be used to supplement traditional therapy to reduce 47 
EIB severity and lessen exercise respiratory symptoms (table 1). This paper reviews the 48 
evidence and provides recommendations for the use of non-pharmacological strategies in the 49 
management of EIB. 50 
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 51 
Table 1. Non-pharmacological strategies to manage EIB 
Strategy Intervention Potential effect Evidence 
level 
Pitfalls References 
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VO2max/HRmax 
Reduces post-
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masks 
Reduces post-
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Respiratory 
muscle training 
30 breaths x 2/d 















FEV1: forced expired volume in 1 s, HME: heat and moisture exchange, HRmax: maximal heart rate, MIP: maximal 52 
inspiratory pressure, ROS: reactive oxygen species, VO2max: maximal oxygen consumption 53 
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PRE-EXERCISE WARM UP 54 
In approximately half of those who suffer from EIB, high intensity pre-exercise warm up 55 
effectively protects against subsequent bronchoconstriction3. A recent systematic review4 56 
reported that intermittent high intensity pre-exercise warm up (repetitive sprints of ~30 s close 57 
to peak oxygen consumption or maximal HR) provides about 10% reduction in the fall in FEV1 58 
post exercise, whereas neither low intensity nor continues high intensity pre exercise warm up 59 
provides significant protection in individuals with EIB.  60 
The refractory period or refractory effect, that is induced after a first exercise bout, has 61 
frequency been proposed to explain why high intensity warm-ups protect against EIB. It has 62 
been proposed that the first exercise induces a variable period (called the refractory period) 63 
during which (2-4 hours) subsequent exercise will not result in EIB or will result in decreased 64 
fall in FEV1. As discussed by XXXX (ref to refractory paper in this series), preceding exercise 65 
may deplete constrictive mediators, induce secretion of protective mediators (particularly 66 
prostaglandins) and cause desensitization of smooth muscle to bronchoconstrictive mediators3. 67 
Regardless of the mechanism, there is good evidence to suggest a clinical benefit of warm ups 68 
in protecting against EIB. 69 
 70 
While high intensity exercise warm-ups may attenuate EIB3-4, the exercise intensity that is 71 
required for the warm-up, may potentially cause perturbations in the exercising musculature 72 
and compromise subsequent exercise performance5. However, emerging evidence suggests that 73 
isolated respiratory warm-ups can provide similar bronchoprotective effects as whole-body 74 
warm up6. Instead of using whole-body warm up, a recent study6 evaluated the effect of a 75 
respiratory-only warm up on subsequent decline in FEV1 induced by exhaustive cycling § 14 76 
min). In that study, subjects performed normocapnic hyperpnoea at different intensities (30-77 
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80% of maximal voluntary ventilation). Notably, all hyperpnoea sessions attenuated post-78 
exercise decline in FEV1 regardless of the intensity of the hyperpnoea session conducted and 79 
without compromising cycling performance6. Perception of respiratory dyspnoea was also 80 
reduced by preceding normocapnic hyperpnoea. Consequently, both pre-exercise whole body 81 
and respiratory warm ups may be used to protect against EIB. 82 
 83 
AVOIDANCE OF TRIGGERS 84 
Heat and Moisture Exchange Face Masks  85 
Exercise in dry and cold environments can be a significant trigger of bronchoconstriction (ref 86 
to paper in series). The bronchoconstriction is thought to be caused by dehydration of the 87 
airway surface liquid, which causes cell shrinkage, release of inflammatory mediators 88 
precipitating airway smooth muscle constriction7. Repeated exposure of the airways to cold 89 
dry air may also lead to airway epithelial cell damage, microvascular leakage and airway 90 
remodelling, which may worsen asthma severity8. Given the increased risk of 91 
bronchoconstriction in dry and cold environments, individuals with asthma may be advised to 92 
avoid exercise outside. This places obvious constraints on athletes with asthma-related 93 
conditions who have to train and complete in dry and cold environment and also the proportion 94 
of individuals with asthma who engage in physical activity as part of their daily routines during 95 
the winter months. 96 
 97 
Face masks that incorporate a heat and moisture exchanger (HME) are a novel non-98 
pharmacological tool to counteract EIB in dry and cold environments. Although few studies 99 
have investigated the efficacy of HME face masks in counteracting EIB, some studies have 100 
demonstrated a protective effect as measured by an attenuation in post-exercise decline in 101 
FEV19-12. This suggests that individuals with asthma may use HME face masks to protect 102 
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against EIB when they engage in moderate to vigorous exercise in cold dry environments. 103 
Currently, it is unknown whether the HME face masks reduce airway inflammation over acute 104 
and multiple bouts of exercise. Nor is it known whether HME face masks reduce respiratory 105 
V\PSWRPV DQG ȕ2-Agonists usage over several weeks of engaging in exercise in dry cold 106 
environments. If HME face masks are to be considered as part of a non-pharmaceutical therapy 107 
plan, the design of the masks need to be considered, as individuals with asthma-related 108 
conditions are unlikely to wear the masks if they find the masks large and cumbersome. 109 
However, athletes may not see HME face masks as a viable strategy to prevent EIB as the 110 
masks may not be practical wear to achieve optimal sporting performance or permitted by the 111 
rules of the sport. 112 
 113 
Air pollution 114 
Air pollution has been shown to increase asthma severity and may have significant effects on 115 
athletes due to the high ventilation rates they achieve and sustain during intense exercise13. Air 116 
quality is inversely correlated with exercise-induced respiratory symptoms14. The risk is also 117 
greater in those athletes who train on a regular basis in environments with poor air quality15. 118 
Small particles, particularly ultra-fine ones (<100 nm diameter) like those from combustion 119 
engines, have high lung deposition and may cause epithelial damage. These particles include 120 
ozone (O3), sulfur dioxide (SO2), nitrogen oxides (NOx) and particulate matter (PM2.5, 121 
particles smaller than 2.5 mic diameter). Ice skaters are particularly exposed to combination of 122 
cold dry air as well as PM1 (PM < 1 mic diameter) in confined space of indoor ice arenas and 123 
multiple ice-resurfacing by gas- or propane-powered machines. Particle inhalations have been 124 
shown to induce oxidative stress, airway inflammation and airway remodelling. All these result 125 
in higher prevalence of asthma symptoms, and great degree of small airway dysfunction16-19.  126 
 127 
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With regard to management, mechanical barriers, such as face masks, may help reduce the 128 
effects of polluted particles9. Avoidance of training in low humidity conditions or during times 129 
of high levels of atmospheric pollutants is advisable, yet its practical usage and scientific 130 
benefit is still questionable. Similarly, whenever possible, it may be recommended to avoid 131 
training close to busy major roadways or during rush hours or other times of elevated vehicular 132 
congestion20. 133 
 134 
Swimming  135 
The pathogenic mechanisms of EIB classically involve both osmolar and vascular changes in 136 
the airways in addition to cooling of the airways2,7. Increased minute ventilation during 137 
exercise, requires significant warming and humidification of the inspired air. The resulting 138 
respiratory heat and water loss from the airway mucosa into the inspired air may release 139 
bronchoconstrictive mediators.  In that respect, sports in warm humid environments, such as 140 
indoor pools, are encouraged. Swimming has often been recommended as a less asthmogenic 141 
trigger compared to other sports, because of the humid environment. Yet, a recent Cochrane 142 
review concluded that there is insufficient evidence to suggest that aquatic-based exercise is 143 
superior to comparative nonaquatic exercise in asthmatics21. 144 
 145 
Chlorination is the most commonly used method for ensuring water hygiene in swimming 146 
pools. Chlorine gas and its aerosol byproducts, (eg, trichloramine, hypochlorous acid, and 147 
mono- and dichloramine), which float just above the water surface, may affect the nose, 148 
pharynx, larynx trachea and bronchi with chronic exposure leading to structural epithelial 149 
changes. During exercise, nasal breathing at rest shifts to oro-nasal breathing, thereby 150 
significantly reducing the filtering effect of the nose. Aerosol particles travel and deposit 151 
further into the lung.  Trichloramine gas formed in chlorinated pools was suggested as a cause 152 
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for EIB in competitive swimmers and increased airway hyperreactivity (as measured by 153 
methacholine or EVH challenge) has been demonstrated in swimmers where 43-68% of them 154 
showed it22-24. Increasing evidence supports the notion that chronic repetitive swimming in 155 
indoor pools may induce airway epithelial damage, inflammation, and remodelling23-25, and 156 
increase the risk for atopy and asthma26,27. A recent study found increased levels of 8-157 
isoprostane (8-IsoP) (as a marker of airway oxidative stress) in the exhale breath condensate of 158 
competitive swimmers after a swimming session27. Whenever possible, swimmers should train 159 
in pools cleaned with non-chlorine water disinfection methods (such as copper/silver and 160 
ozone) as well as in well ventilated pool environments. Yet, apart for some case reports29, the 161 
scientific evidence to support or refute many of these recommendations is lacking. 162 
 163 
DIETARY STRATEGIES 164 
Omega-3 fatty acid supplementation  165 
It has been noted that populations who consume large quantities of oily fish have a lower 166 
prevalence of asthma30. Oily fish are rich in omega-3 fatty acids: eicosapentaenoic acid (EPA) 167 
and docosahexaenoic acid (DHA). EPA and DHA are precursors to powerful agents involved 168 
in the resolution of inflammation. Two mechanisms of action underpinning the anti-169 
inflammatory bio-actions include the ability of EPA to compete with arachidonic acid as a 170 
substrate for cyclooxygenase (COX)-2 and 5-lipoxygenase (5-LO) enzymes and be converted 171 
to less inflammatory leukotrienes and prostanoids31, and to generate the potent anti-172 
inflammatory E-series resolvins31. DHA may also alter gene transcription and translation via 173 
direct or indirect actions on intracellular signalling pathways33. 174 
 175 
The anti-inflammatory properties of EPA and DHA make a diet high in oily fish an attractive 176 
addition to the therapy of an individual with EIB.  Initial investigations demonstrated 10 weeks 177 
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dietary supplementation of 3.2 g/d EPA and 2.2 g/d DHA reduced leukotriene production by 178 
50%, but not reduction in post-exercise decline in FEV1 in asthmatics34. However, using the 179 
same EPA and DHA dietary supplementation over a three week period, Mickleborough and 180 
co-workers reported significant reductions in airway inflammation, which was accompanied 181 
by 64-80% reductions in FEV1 fall post exercise in individuals with EIB35,36. Notably, post-182 
exercise decline in FEV1, whilst on EPA and DHA supplementation, was similar to those of 183 
the non-EIB control group. In addition, 3.2 g/d EPA and 2 g/d DHA were observed to be as 184 
favourably as 10 mg/d montelukast in reducing airway inflammation and hyperpnoea-induced 185 
bronchoconstriction in participants with mild to moderate persistent asthma37. However, there 186 
appears to be no additional benefit of combining EPA and DHA supplementation with 10 mg 187 
montelukast37. Furthermore, a recent pilot study found no beneficial effect of vitamin D and 188 
fish oil supplementation for 3 weeks on reduction in FEV1 induced by EVH in recreational 189 
athletes with EIB38. 190 
 191 
Recently, the marine lipid fraction of the New Zealand green-lipped mussel (Perna canaliculus) 192 
PCSO-524, which is rich in omega-3 fatty acids, has been shown to produce similar reductions 193 
in inflammation and bronchoconstriction (57% reduction of FEV1 fall) following a eucapnic 194 
voluntary hyperpnoea challenge39. In this investigation the attenuation of airway inflammation 195 
and bronchoconstriction cannot be explained entirely by the EPA and DHA content of PCSO-196 
524, since the amount of EPA and DHA consumed daily was only 72 mg and 48 mg 197 
respectively.  Therefore, it may be that the additional constituents of PCSO-524 act 198 
synergistically with EPA and DHA to bring about the anti-inflammatory effect and reduction 199 
in bronchoconstriction.  200 
 201 
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While a low intake of EPA and DHA does not appear to be a safety issue a few side effects can 202 
occur, such as a fishy aftertaste, flatulence, acid reflux, bloating, diarrhoea, nausea and possibly 203 
an increased risk of bleeding and immunosuppression with a high intake of omega-3 fatty 204 
acids40. The initial investigations provide promise for EPA and DHA dietary supplementation 205 
to protect against EIB and associated airway inflammation. However, large-scale clinical 206 
studies in individuals with EIB are required to determine the minimum effective dose, duration 207 
required to observe the beneficial effect and compare the effect of combining omega-3 fatty 208 
acid supplementation with prevention inhaler therapy (e.g. inhaled glucocorticoids). 209 
 210 
Caffeine 211 
Caffeine (1,3,7-trimethylxanthine) is among the most commonly used supplements by 212 
athletes41. While formerly being subjected to anti-doping regulations, the restrictions towards 213 
caffeine were lifted by the World Anti-Doping Agency (WADA) in 2004 and can as such be 214 
used freely in and out of competition. Caffeine works as a non-selective competitive adenosine 215 
receptor antagonist for all subtypes of the adenosine receptor42,43, but may also act as a 216 
phosphodiesterase inhibitor44. Accordingly, caffeine induces intracellular cAMP-217 
dHSHQGHQWSURWHLQ NLQDVH $ VLJQDOOLQJ ZKLFK OLNH ȕ2-Agonists, causes smooth muscle 218 
relaxation45. Indeed, studies have shown dose-related bronchodilator effects of caffeine on 219 
basal airway function46. The interest in caffeine as a bronchoprotective agent started some 30 220 
years ago when Becker and co-workers (1984) observed that 10 mg/kgbw of orally ingested 221 
caffeine had a similar bronchodilating effect as 5 mg/kgbw oral theophylline in children with 222 
asthma47. Comparable bronchodilating effect was later shown in adult asthma patients after 223 
ingestion of 5 mg/kgbw caffeine47 or 3 cups of coffee49.  224 
 225 
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Although caffeine shows promise as a bronchodilator, only a few studies have investigated its 226 
potential to counteract EIB of which none have been performed in athletes. In non-athletes, 227 
ingestion of caffeine was shown to have a post-exercise bronchoprotective effect compared to 228 
placebo in individuals with EIB50. While post-exercise decline in FEV1 was 24% for placebo, 229 
it was less than 1% after ingestion of 7 mg/kgbw caffeine and 8% after 3 mg/kgbw caffeine. In 230 
accordance with this observation, Duffy & Phillips (1991) observed that ingestion of 10 231 
mg/kgbw caffeine reduced bronchoconstrictor response to EVH-provocation compared to 232 
placebo in EVH-positive individuals51. :KHQFRPSDUHGWRLQKDODWLRQRIȕ2-Agonist salbutamol 233 
(180 mg albuterol), ingestion of 9 mg/kgbw caffeine was shown to be as effective as salbutamol 234 
in attenuating post-exercise reduction in FEV1 in asthmatics with EIB52.  235 
 236 
Aside from its bronchoprotective effect, caffeine has a variety of other effects of relevance for 237 
airway function during exercise. During submaximal exercise, as little as 3 mg/kgbw oral 238 
caffeine has been shown to modulate ventilatory dynamics by reducing the physiological dead 239 
space ventilation/tidal volume ratio and breathing frequency, while concurrently increasing 240 
tidal volume53,54. In addition, caffeine may counteract exercise-induced hypoxemia 241 
(desaturation) in elite athletes at submaximal intensities55 and improve respiratory muscle 242 
fatigue resilience56. 243 
 244 
Despite the small number of studies undertaken, there is some evidence to suggest that caffeine 245 
has the potential to reduce EIB severity and improve ventilatory dynamics and respiratory 246 
muscle fatigue resilience during exercise. The amount of orally ingested caffeine needed for 247 
bronchoprotection is approximately 5-10 mg/kgbw, which would be equivalent to 2-4 cups of 248 
coffee. However, it appears that the bronchoprotective effect of caffeine is highly individual. 249 
A limitation of caffeine is the slow absorption rate when ingested, giving rise to a 250 
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bronchodilator response 2 hours after ingestion. Future studies should investigate more 251 
thoroughly the therapeutic efficacy of caffeine as a bronchoprotective substance during 252 
exercise in athletes with EIB. 253 
 254 
Vitamins and anti-oxidants 255 
Supplementation with various vitamins and anti-oxidants has attracted some attention as means 256 
to counteract EIB because of their ability to suppress proinflammatory signalling57, to lower 257 
levels of histamine58,59 DQG SURVWDJODQGLQ )Į60, and to scavenge reactive oxygen species 258 
(ROS)61,62. In practical terms, however, interpretation of the therapeutic efficacy of each 259 
individual vitamin and anti-oxidant as bronchoprotective substances in EIB is limited by the 260 
small number of studies that have been undertaken in individuals with EIB, especially in 261 
athletes. Most convincing is the bronchoprotective effect of acute and chronic supplementation 262 
with vitamin C on post-exercise decline in FEV1 in individuals with EIB60,63-65. In addition, 263 
RQH ZHHN VXSSOHPHQWDWLRQ ZLWK ȕ-carotene (64 mg), a provitamin A carotenoid, has been 264 
shown to reduce post-exercise reduction in FEV166. Conflicting results have been observed 265 
after one week supplementation with the carotenoid lycopene (30 mg), in which a post-exercise 266 
bronchoprotective effect was found in asthmatic individuals with EIB, whereas adolescent 267 
athletes with EIB had no effect67,68. 268 
 269 
STRATEGIES TO REDUCE PERCEPTION OF EXERTIONAL DYSPNOEA 270 
Above we have discussed strategies that may help control EIB. In addition, there may also be 271 
a role for utilising breathing control and inspiratory muscle training in order enable athletes 272 
with EIB to reduce perceptions of exertional dyspnoea. 273 
 274 
 275 
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Breathing control 276 
A significant symptom of EIB is dyspnoea during and after exercise. There are a variety of 277 
breathing exercises that may benefit individuals who experience asthma/EIB exacerbations that 278 
include yogic breathing69-71 and physiotherapist-supervised breathing training72. Although 279 
these forms of breathing control exercises may not be able to reduce asthma severity they may 280 
be able to reduce the perception of respiratory symptoms and increase perception of asthma 281 
control69.  Moreover, breathing exercises have been shown to improve quality of life70, reduce 282 
use of relief medication70, reduce the levels of anxiety and depression72 and airway 283 
hyperresponsiveness71. Future research is required to understand the mechanisms behind these 284 
observations in asthmatic individuals. 285 
 286 
It is currently unknown how these forms of breathing control exercises may be beneficial for 287 
athletes with EIB, whose main symptoms are experienced during exercise. However, the use 288 
of breathing training incorporating, inspiratory muscle training and breathing technique 289 
training (table 2), has been shown to be helpful in reducing the perception of breathing in an 290 
athlete with non-asthmatic exercise respiratory conditions73. Future research is required to 291 
investigate how athletes with EIB respond to using breathing exercises. Furthermore, the 292 
current breathing control methods may need to be adapted to replicate respiratory control 293 
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Breathing Technique Encourage initiation of inspiration from the lower rib cage. 
Inspiratory manoeuvre should be smooth with little tension 
through the shoulders and neck. Aids such as elastic strap or 
hands placed on sides of torso over lower ribs can be used to 
help athletes. Athlete can begin to attempt to practice this 
technique in functional sport specific positions 
Inspiratory Muscle 
Training (IMT) 
Ensure breathing technique is addressed before initiating IMT. 
Athletes with poor breathing technique, who proceed directly to 
IMT, may experience exacerbation of their symptoms. IMT 
should incorporate forceful inspiratory manoeuvres through a 
hand-held device providing resistance to the inspired airflow. 
Focus during the IMT should be on good breathing technique 
(as described above). An IMT session should comprise of 30 
continuous forced inspiratory efforts at the equivalent of 30 
breath repetition maximum, with relaxed expiration. 
Adapted from Dickinson, J.  McConnell A. Ross E. Brown, P. Hull, J. Assessment and 302 
Management of Non-Asthma Related Breathing Problems in Athletes. The Sport and Exercise 303 
Scientist. 2015; 45: 8-9 304 
 305 
Respiratory Muscle Training  306 
Respiratory muscle training is an easy and cheap way to enhance both inspiratory and 307 
expiratory muscle strength74, and has also been associated with improvements in exercise 308 
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performance during various exercise protocols in healthy individuals75,76. However, despite 309 
decades of research into the applications of respiratory muscle training, the area is still 310 
controversial and subject to scientific debate77-79. Respiratory muscle training has shown some 311 
promise in the management of chronic obstructive pulmonary disease80, inspiratory stridor73 312 
and exercise-induced vocal cord dysfunction81,82. However, although studies also have shown 313 
that respiratory muscle training may have beneficial effects on asthma severity and beta2-314 
agonist usage83-85, a recent cochrane review, based on 113 asthmatics, concluded that there is 315 
no conclusive evidence to support or refute the therapeutic efficacy of inspiratory muscle 316 
training in asthma86. Nevertheless, given individuals with EIB may experience airway 317 
obstruction and airflow limitation during intense exercise87, which potentially puts a larger 318 
work load on respiratory muscles3,88, it could be speculated that respiratory muscle training 319 
may be beneficial for athletes with EIB. However, to our knowledge, no studies have 320 
investigated the effectiveness of respiratory muscle training on EIB severity89.  321 
 322 
SUMMARY AND FUTURE CONSIDERATIONS 323 
There are numerous non-pharmacological strategies that can be utilised to support the treatment 324 
of EIB, however the evidence is inconclusive and future studies are encouraged before any 325 
recommendations are implemented. There is currently insufficient evidence to support the use 326 
of any non-pharmacological EIB treatment strategy in the absence of regular pharmaceutical 327 
therapy for EIB. While there is some encouraging findings with regards to nutritional 328 
supplementation and respiratory muscle training, future studies are encouraged, especially in 329 
athletes. Most studies have included non-athletes and extrapolation towards athletes should 330 
therefore be done with caution. Furthermore, data on other commonly used supplements by 331 
athletes, such as beta-alanine and creatine are lacking in relation to EIB. For instance, beta-332 
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alanine supplementation increases intracellular content of carnosine, which among other 333 
factors90, may affect nitric oxide production and modulate inflammation91,92, both of which 334 
could affect EIB severity. In addition, creatine supplementation has been shown to exacerbate 335 
airway inflammation, increase airway hyperresponsiveness and induce smooth muscle 336 
thickening in mice93. However, no studies, have to our knowledge, investigated the effect of 337 
creatine supplementation on EIB severity in athletes. Consequently, there are numerous non-338 
pharmacological strategies yet to be studied in athletes with EIB.  339 
 340 
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